Latest Interviews
Showing 1–6 of 6 transcripts.
Clear all filters- All-In Podcast14 min
Why Are So Many Companies Going Bankrupt In 2025? - David Friedberg
David Friedberg, Chamath, Jason, Sax, Nick
S&P Global reports a record 446 large corporate bankruptcies through July 2025, a surge Chamath Palihapitiya attributes to the exhaustion of pandemic-era liquidity and rising interest rates that finally forced the liquidation of "zombie" businesses. While this correction disproportionately impacts retail and commercial real estate sectors facing refinancing walls, the event suggests a broader economic strength with Q2 GDP restated at 3.03% despite distressed market conditions. The discussion concludes with a warning that Federal Reserve policies may be delaying necessary adjustments, potentially prolonging the reallocation of capital away from struggling traditional assets toward more efficient sectors like data centers.
- All-In Podcast7 min
The Brutal Truth About Jerome Powell & Future Rate Cuts - David Friedberg
Jerome Powell, David Friedberg, Chamath, Jason, Gavin
Market expectations have shifted toward a Federal Reserve pause, while the 30-year Treasury yield has surged to 5%, signaling a critical shift where annual debt interest costs on the $36 trillion national debt could nearly double to $2 trillion. This escalation challenges the efficacy of short-term monetary policy, as historical data shows the deficit remains constrained by sustained high borrowing costs rather than just central bank actions. Analysts conclude that addressing this fiscal crisis requires a "virtuous cycle" driven by specific structural changes, such as spending restraint, revenue generation through tariffs, and tax reforms, to eventually lower long-term yields and prevent interest payments from eclipsing major federal expenditures.
- All-In Podcast13 min
"What The F Are We Doing?" David Friedberg On BBB’s Deficit Increase & Trump vs. Elon
The White House and Treasury officials, including Scott Besson and Ray Dalio, are advocating for a "333" economic strategy to reduce the federal deficit-to-GDP ratio to 3% while stimulating 3% growth and controlling inflation. This approach relies on unproven variables such as tariff revenue and tax cuts, facing skepticism from economists who warn that current structural incentives in Congress and massive hidden liabilities make the target unachievable without monetary expansion. Concurrently, analysts project a strategic pivot for Elon Musk to leverage his $250 million in political expenditures to define a specific "America Pack" focused on balanced budgets and sustainable energy, aiming to influence policy without engaging in direct conflict with the Trump administration.
- All-In Podcast11 min
David Friedberg Reacts to Zohran Mamdani’s NYC Mayoral Run
David Friedberg, Zohran Mamdani, Chamath, Jason, Nick, Sax
Assemblyman Zoryn Mamdani defeated former Governor Andrew Cuomo to secure the New York Democratic nomination, capitalizing on a 39-point margin among college-educated voters. Mamdani's victory platform centers on aggressive socialist policies, including a $30 minimum wage, police defunding, and free public transit, driven by a demographic shift caused by $1.5 trillion in student debt. While analysts project this trend will reshape the national political landscape toward socialism, critics warn of economic collapse and capital flight similar to the "doom spirals" observed in San Francisco and Los Angeles.
- All-In Podcast7 min
Mitotherapy Breakthrough: Supercharging Your Cells ⚡️| Science Corner with David Friedberg
Recent breakthroughs in mitochondrial biology have established physical transfer between cells and enabled the engineered amplification of mitochondria to produce 854 times normal ATP output. These advancements allow researchers to successfully repair cartilage and bone in osteoarthritis models while creating detailed brain maps that link mitochondrial dysfunction to cognitive decline. Consequently, this supply solution is launching "mitotherapy" as a viable clinical modality for treating sports injuries, heart attacks, and neurodegenerative diseases.
- All-In Podcast12 min
Science Corner with David Friedberg: GLP-1 Study Shows Encouraging Results
David Friedberg, Chamath, Jason, Antonio, Dave, Jamal
Researchers analyzing 2 million anonymized VA medical records identified that GLP-1 agonists significantly reduce risks of cardiac arrest, hepatic failure, and schizophrenia while triggering anti-inflammatory molecular mechanisms beyond simple weight loss. Despite mild adverse effects such as nausea and potential muscle loss, industry experts and speakers emphasized that combining these drugs with rigorous protein intake and weightlifting offers superior preventative outcomes compared to fragmented medical advice or unproven protocols. As pharmaceutical companies like Eli Lilly advance trials for non-obesity indications, the prevailing consensus advocates for a simplified "core four" approach of sleep, exercise, diet, and meditation to maximize healthspan and mitigate cognitive overload.